![](https://investorshub.advfn.com/uicon/96928.png?cb=1517144672)
Monday, February 01, 2016 6:34:09 PM
http://fibromyalgianewstoday.com/2015/01/21/premier-biomedical-submit-fibromyalgia-therapy-fda/
http://google2.fda.gov/search?q=Feldetrex&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&requiredfields=-archive%3AYes&output=xml_no_dtd&getfields=*
Premier Biomedical Inc. has announced it will submit an application to the U.S. Food and Drug Administration (FDA) with the purpose of selling an exclusively licensed and patented drug therapy designed for the treatment of fibromyalgia. The company is now expecting to discuss with the agency the requirements needed regarding both clinical studies and possible marketing approval to commercialize Feldetrex, as announced in a press release.
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM